[Federal Register Volume 68, Number 72 (Tuesday, April 15, 2003)]
[Notices]
[Pages 18262-18263]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-9229]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importation of Controlled Substances; Notice of Application

    Pursuant to section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
issuing a registration under this section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
registration under section 1002(a) authorizing the importation of such 
a substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with section 1301.34 of title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on May 20, 2002, 
Tocris Cookson, Inc., 16144 Westwoods Business Park, Ellisville, MO 
63021-4500, made application to the Drug Enforcement Administration to 
be registered as an importer of Tetrahydrocannabinols (7370), a basic 
class of controlled. Any manufacturer holding, or applying for, 
registration as a bulk manufacturer of this basic class of controlled 
substances may file

[[Page 18263]]

written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.43 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections or requests for a hearing may be 
addressed, in quintuplicate, to the Deputy Assistant Administrator, 
Office of Diversion Control, Drug Enforcement Administration, United 
States Department of Justice, Washington, DC 20537, Attention: Drug 
Operations Section, Domestic Drug Unit (ODOD), and must be filed no 
later than May 15, 2003. This procedure is to be conducted 
simultaneously with and independent of the procedures described in 21 
CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice 
at 40 FR 43745-46 (September 23, 1975), all applicants for registration 
to import the basic class of any controlled substances in Schedule I or 
II are and will continue to be required to demonstrate to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration that the requirements for such registration pursuant to 
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(a), (b), (c), 
(d), (e), and (f) are satisfied.

    Dated: April 3, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-9229 Filed 4-14-03; 8:45 am]
BILLING CODE 4410-09-M